This inventor holds 1 USPTO granted patent. Top assignee: National Taiwan Normal University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Guey-Jen Lee in Neurodegenerative Disorder Research
Introduction: Guey-Jen Lee is an accomplished inventor based in Taipei, Taiwan. He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patented inventions. His work focuses on addressing the challenges posed by abnormal protein aggregation and oxidative stress in brain tissues.
Latest Patents: Guey-Jen Lee holds a patent for a NiSOD-like compound and its derivatives. This invention aims to suppress abnormal protein aggregation, recover cell viability, increase mature neuron numbers, and enhance neurite outgrowth length. Additionally, it protects dopaminergic cells by reducing oxidative stress or reactive oxygen species in brain tissues. The patent addresses the accumulation of abnormal proteins in neurodegenerative disorders, which is believed to induce oxidative stress and lead to cell death. The invention provides a potential avenue for the prevention and treatment of disorders such as spinocerebellar ataxia (SCA), Alzheimer's disease (AD), and Parkinson's disease (PD).
Career Highlights: Guey-Jen Lee is affiliated with National Taiwan Normal University, where he conducts his research. His work has been instrumental in establishing several cell and animal experiment models for SCA, AD, and PD. The results from these experiments have demonstrated the efficacy of NiSOD-like compounds in suppressing abnormal protein aggregation and promoting neuronal health.
Collaborations: Guey-Jen Lee has collaborated with notable colleagues, including Way-Zen Lee and Hsiu-Mei Hsieh, who contribute to his research endeavors.
Conclusion: Guey-Jen Lee's innovative work in developing NiSOD-like compounds represents a significant advancement in the fight against neurodegenerative disorders. His research holds promise for improving the lives of individuals affected by these debilitating conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile